800-742-7730     This email address is being protected from spambots. You need JavaScript enabled to view it.     Offices     News     Family of Companies

NHLD logo
NAM Logo
NationalInsurance Logo
vfin logo
GC logo

Jonathan Aschoff

Jonathan Aschoff, Ph.D. is a Managing Director and Senior Biotechnology Analyst.

Dr. Aschoff was a Managing Director and Senior Biotechnology Analyst at Brean Capital, LLC from 2003 to 2016. Prior to Brean, Dr. Aschoff held positions as a senior biotechnology analyst at Friedman Billings Ramsey & Co., Inc., senior analyst at what is now RBC Dain Rauscher, Inc. and also served as an analyst at Sturza Institutional Research. Prior to beginning his career on Wall Street, Dr. Aschoff earned his Ph.D. in Molecular Biology and Microbiology as well as his B.S. in Biology at Tufts University.

Current Coverage:

AKBA        Akebia Therapeutics, Inc.

ALDR        Alder BioPharmaceuticals, Inc.

HRTX        Heron Therapeutics, Inc.

PGNX        Progenics Pharmaceuticals, Inc.

REPH        Recro Pharma, Inc.

SCYX        SCYNEXIS, Inc.

TRVN        Trevena, Inc.

NHLD logo
NAM Logo
NationalInsurance Logo
vfin logo
GC logo

Newsletter Sign Up

News letter